HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

Nuhad K Ibrahim Selected Research

Nuhad K Ibrahim Research Topics

Disease

23	Breast Neoplasms (Breast Cancer) 11/2015 - 01/2002
16	Neoplasms (Cancer) 11/2015 - 05/2002
4	Disease Progression 11/2011 - 01/2010
4	Carcinoma (Carcinomatosis) 01/2009 - 06/2003
3	Hypersensitivity (Allergy) 09/2006 - 05/2002
2	Neoplasm Metastasis (Metastasis) 05/2015 - 04/2010
2	Colitis 04/2008 - 10/2004
2	Heart Failure 06/2005 - 11/2002
1	Edema 11/2015
1	Residual Neoplasm 10/2015
1	Brain Neoplasms (Brain Tumor) 05/2015
1	Thrombocytopenia (Thrombopenia) 01/2009
1	Ischemic Colitis 04/2008
1	Neutropenia 09/2005
1	Abdominal Pain (Pain, Abdominal) 10/2004
1	Ovarian Neoplasms (Ovarian Cancer) 11/2002

Drug/Important Bio-Agent (IBA)

9	Paclitaxel (Taxol)FDA LinkGeneric 03/2012 - 05/2002
7	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2012 - 06/2005
6	Fluorouracil (Carac)FDA LinkGeneric 03/2012 - 06/2005
4	docetaxel (Taxotere)FDA Link 11/2015 - 01/2002
4	TaxoidsIBA 10/2015 - 09/2006
4	taxaneIBA 05/2015 - 10/2004
4	albumin-bound paclitaxel FDA Link 05/2015 - 05/2002
4	Estrogens (Estrogen)FDA Link 05/2015 - 04/2010
3	HormonesIBA 05/2015 - 06/2006
3	sialyl-Tn antigen-keyhole-limpet hemocyanin conjugateIBA 01/2013 - 02/2003
3	Epirubicin (Ellence)FDA LinkGeneric 03/2012 - 06/2005
3	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2010 - 11/2002
3	Epidermal Growth Factor Receptor (EGF Receptor)IBA 04/2010 - 06/2005
2	ixabepilone (BMS 247550)FDA Link 10/2015 - 01/2010
2	Biological Markers (Surrogate Marker)IBA 05/2015 - 01/2011
2	vinorelbine (Navelbine)FDA LinkGeneric 01/2014 - 01/2002
2	gemcitabine FDA Link 01/2014 - 01/2009
2	keyhole-limpet hemocyanin (keyhole limpet hemocyanin)IBA 01/2013 - 01/2011
2	capecitabine (Xeloda)FDA Link 03/2012 - 01/2010
2	AntigensIBA 11/2011 - 02/2003
2	thymidine 5'-triphosphate (TTP)IBA 01/2011 - 05/2010
2	AnthracyclinesIBA 05/2010 - 01/2010
2	trastuzumab (Herceptin)FDA Link 01/2007 - 06/2005
2	Tamoxifen FDA LinkGeneric 06/2006 - 05/2002
1	Progesterone Receptors (Progesterone Receptor)IBA 05/2015
1	Immunoglobulins (Immunoglobulin)IBA 11/2011
1	letrozole (Femara)FDA LinkGeneric 11/2011
1	bavituximabIBA 11/2011
1	AS 1402IBA 11/2011
1	PolysaccharidesIBA 01/2011
1	Globo-HIBA 01/2011
1	Indicators and Reagents (Reagents)IBA 01/2011
1	GlycoconjugatesIBA 01/2011
1	Leucovorin (Folinic Acid)FDA Link 05/2010
1	TegafurIBA 05/2010
1	UracilIBA 05/2010
1	Epothilones (Epothilone)IBA 01/2010
1	Aromatase InhibitorsIBA 06/2006
1	RNA (Ribonucleic Acid)IBA 06/2003
1	Glycoproteins (Glycoprotein)IBA 02/2003
1	EpitopesIBA 02/2003
1	MucinsIBA 02/2003
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 11/2002
1	Estrogen ReceptorsIBA 05/2002
1	cremophor ELIBA 05/2002
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2002

Therapy/Procedure

11	Drug Therapy (Chemotherapy) 01/2013 - 05/2002
3	Neoadjuvant Therapy 01/2007 - 06/2005
3	Premedication 09/2006 - 05/2002
1	Craniotomy 05/2015
1	Mammaplasty (Breast Reconstruction) 09/2006
1	Immunotherapy 02/2003
1	Adjuvant Chemotherapy 05/2002